Study finds increased STI risk among transgender women with HIV
February 6th 2024A recent study found that transgender women with HIV face elevated risks of bacterial sexually transmitted infections, emphasizing the need for tailored interventions and further research to address the distinct challenges faced by this population.
Read More
Protecting HIV-positive adolescents against high-risk HPV types
February 5th 2024A recent study found that the Gardasil quadrivalent HPV vaccine effectively shields HIV-positive adolescents from high-risk HPV types 16, 18, 6, and 11, shedding light on the potential for HPV vaccination to mitigate cancer risks in this vulnerable population.
Read More
FDA clears Genius Digital Diagnostics System for cervical cancer screening
February 2nd 2024Hologic's Genius Digital Diagnostics System, the first FDA-cleared digital cytology system using AI and advanced imaging, promises improved sensitivity in detecting pre-cancerous lesions and cervical cancer cells.
Read More
Oteseconazole outperforms fluconazole in treating severe vulvovaginal candidiasis
January 31st 2024A phase 3 trial demonstrated that oteseconazole (VIVJOA; Mycovia Pharmaceuticals) capsules exhibit improved therapeutic and mycological cure rates to fluconazole for treating severe vulvovaginal candidiasis.
Read More
COVID-19 vaccination during pregnancy not linked to preterm birth
January 31st 2024A systematic review of 6 studies revealed that COVID-19 vaccination during pregnancy does not significantly increase the risk of preterm birth, providing crucial insights for public health policies and offering reassurance to healthcare providers and expectant mothers.
Read More
Two-dose HPV vaccination postpartum shows efficacy
January 30th 2024A recent study revealed a 2-dose regimen of human papillomavirus vaccination in postpartum individuals is as effective as a 3-dose approach, providing valuable insights into optimizing vaccination strategies against the virus.
Read More
Metabolomics and proteomics linked to female infertility
January 30th 2024Dive into the latest research in metabolomics and proteomics, revealing potential biomarkers like fibrinogen cleavage peptides and GRAM domain-containing protein 1C, offering new avenues for diagnosis and treatment in addressing the global issue of female infertility.
Read More
Discussing the link between bacterial vaginosis and vulvovaginal candidiasis
January 25th 2024Explore the relationship between bacterial vaginosis and vulvovaginal candidiasis as revealed by a recent study, uncovering mixed interactions, antibiotic implications, and the potential role of vaginal microbiota in shaping this complex association.
Read More
No link found between prenatal stress and heart disease in offspring
January 25th 2024A recent study challenged the hypothesis of maternal stress during pregnancy as a significant risk factor for ischemic heart disease and stroke in younger patients, shedding light on the nuanced relationship between prenatal stress and cardiovascular health.
Read More
Perinatal depression linked to suicidal behavior
January 25th 2024A recent study indicated perinatal depression significantly increases the risk of suicidal behavior, particularly within the first year post-diagnosis, emphasizing the need for targeted interventions in this vulnerable population.
Read More
Early nurse home visits linked to reduced obesity and hypertension risks
January 24th 2024A recent study revealed that the Nurse-Family Partnership's infant and toddler home visits significantly decrease obesity and hypertension risks in mothers and female offspring, emphasizing the potential cost-saving impact on physical health outcomes.
Read More
Study finds buprenorphine reduces congenital malformation risk in infants
January 24th 2024A recent study revealed that infants exposed to buprenorphine during the first trimester exhibit a significantly decreased risk of developing congenital malformations associated with opioid exposure compared to infants exposed to methadone.
Read More
New guidelines revealed for no-cost FDA-approved contraceptives
January 23rd 2024The Biden-Harris administration, has released comprehensive guidance through Frequently Asked Questions to eliminate barriers to contraception, ensuring access to FDA-approved contraceptives at no cost, following President Biden's 2023 Executive Order.
Read More
Pregnancy complications and future type 2 diabetes risk
January 23rd 2024New research has revealed that postmenopausal women with a history of gestational diabetes and adverse pregnancy outcomes face an increased risk of developing type 2 diabetes, emphasizing the need for preventive measures.
Read More
Isthmic contractions and pregnancy assessment: New ultrasound insights
January 22nd 2024A recent study highlighted how isthmic contractions, commonly observed after second-trimester bladder voiding, can impact cervical length measurements during pregnancy, emphasizing the need for cervical assessments at least 20 minutes post-bladder voiding for accurate results.
Read More